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Abstract: The leading pathophysiological changes during sepsis include systemic abnormalities in the immune
response. Due to the general character of these disturbances, sepsis is usually studied as a homogenous clinical
condition. We aimed to compare the immune response in intraabdominal sepsis (IAS) and pneumonia-derived
sepsis (PDS). The following cell populations were examined: white blood cell count (WBC), monocytes, lym-
phocytes: CD3+, CD4+ and CD8+ T cells, B cells, and NK cells. In both studied groups (i.e. IAS and PDS), the
WBC was elevated. However, it was significantly higher in the IAS group than in the PDS group. The difference
was due to a lower granulocyte count, as well as a lower monocyte count in PDS. We found no significant
correlation between the total lymphocyte number and CD3+CD8+ T cells in either form of sepsis. Similarly, we
observed no correlation between the total lymphocyte number and the NK cells subset in IAS. However, the
numbers of CD3+CD8+ and NK cells correlated similarly in both types of sepsis. Both studied types of sepsis
induced profound lymphocytopenia, with marked loss of CD8+ T cells and the NK cells. However, the similar
relation between them, which was independent of the infection type, suggests that the NK and CD3+CD8+ cells
have shared mechanisms of regulation. The primary site of infection has an impact on the global immune reaction.
These alternations include especially myeloid cells: granulocytes and monocytes which disappear from peripheral
blood during PDS, but increase in IAS. (Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 3, 420–426)
Key words: intraabdominal sepsis, pneumonia-derived sepsis, flow cytometry, natural killer cells,
cytotoxic T lymphocytes
Introduction
Sepsis remains the main cause of death in intensive
care units (ICU) in the United States and Europe.
Although mortality rates in sepsis have been slightly
reduced, the occurrence of sepsis is still growing [1].
The increase in the number of septic patients is relat-
ed to more invasive medical procedures, the devel-
opment of peritoneal nutrition techniques, and the
ageing of populations. Due to the introduction of sep-
sis bundles and the improvement of standard thera-
pies, mortality in sepsis is decreasing [2]. However,
the outcome of generally applied therapies is not sat-
isfactory. As immune system dysfunction is thought
to be crucial in the pathophysiology of sepsis, more
studies in this field are necessary.
It is known that the first stage of the septic reac-
tion is characterized by hyperactivity of the immune
system. Leukocytosis, a massive production of pro-
(TNF, IL1, IL6, etc) and anti- (IL10, TGFb, IL1Ra,
etc) inflammatory cytokines, is typical [3]. The release
of inflammatory cytokines is responsible for many
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septic symptoms, like hypotension and hypoperfusion.
This state is followed by the reaction called the com-
pensatory antiinflammatory system (CARS), which
is characterized by an increased concentration of an-
tiinflammatory mediators, in particular IL-10. CARS
also typically involves a decrease in the number of
lymphocytes, especially CD4(+) cells, B cells, and
monocytes [3]. The immunosuppressive effect of sep-
sis also includes profound dysfunctions of phagocytic
activity, antigen presentation, lymphocyte prolifera-
tion and production of cytokines. Altogether, these
events may result in secondary infections and thera-
peutic failure.
Sepsis is a generalized response to an infection
which can originate in different sites, e.g. lung, abdo-
men, urinary tract, or the site of the central venous
catheter placement. Most research papers do not dis-
tinguish sepsis according to the site of the primary
infection. Some studies have compared the immune
response to Gram positive and Gram negative patho-
gens, which may also be related to the infection site
[4]. In this study, we have compared selected compo-
nents of the cellular immune response in sepsis of pneu-
monia and peritonitis origin during the later phase of
the sepsis (4–6 days). Both types of infection are com-
mon clinical problems and quite often become a source
of sepsis. We chose lungs and the peritoneal cavity as
the primary of infection sites due to their unusual and
specific immune regimens. Although both are parts of
the immune system, they are also site-specific and dif-
fer from each other significantly [5, 6]. Moreover, there
was some suggestion from the study into the applica-
tion of an activated protein C in sepsis (PROWESS)
that patients with sepsis derived from pneumonia may
have greater benefit from this biological therapy [7]. We
focused on patients in septic shock who were in a criti-
cal state. To the best of our knowledge, there has previ-
ously only been one paper focusing on the early cellular
response in sepsis derived from different sites [8].
Material and methods
Patients. The study was approved by the Postgraduate Med-
ical School Center Ethics Committee. Sampling and labo-
ratory analyses were performed in the Intensive Care Unit
(ICU) of the Postgraduate Medical School Center, War-
saw, Poland, and written informed consent was provided by
patients, or by two anesthesiology and intensive care spe-
cialists if the patient was unconscious. Between four and six
days after the diagnosis of sepsis, circulating leukocytes of
22 patients with septic shock were analyzed. Also, 21 healthy
subjects were analyzed as controls. We used flow cytometry
to evaluate and monitor the blood lymphocyte subpopula-
tions in a cohort of therapy-resistant patients who formed
the source of data for this study. Patients were chosen based
on the diagnosis of sepsis originating from pneumonia or
peritonitis. The sepsis diagnostic criteria were based on
ACCP/SCMM Consensus Conference definitions [9]. Brief-
ly, sepsis was diagnosed in patients with a confirmed or sus-
pected infection and at least two of the following: hyperther-
mia (> 38°C) or hypothermia (< 36°C), heart rate > 90/min,
tachypnea (> 24/min), white blood cell (WBC) count less
than 4,000 cells/μl or greater than 12,000 cells/μl or the pres-
ence of more than 10% immature neutrophils (band forms).
Pneumonia-derived sepsis was diagnosed when sepsis
was accompanied by consolidations in chest X-ray, and no
other site of infection. Positive blood and bronchioalveolar
lavage (BAL) fluid bacteria cultures were obtained.
Intraabdominal sepsis was diagnosed when sepsis was
secondary to abdominal surgery complications or severe ne-
crotizing pancreatitis with no other site of infection.
Positive peripheral blood bacteria cultures and perito-
neal fluid culture were obtained from all patients. We ex-
cluded patients under 18 years of age, cancer patients, HIV
carriers and those receiving immunosuppressive treatment.
The clinical severity of the patient’s state was evaluated us-
ing the APACHE II scale.
Flow cytometry analysis. The blood samples for immuno-
cytochemical analysis were collected from selected patients
on average on the fifth day (between the fourth and the
sixth day) of their stay at the ICU (Tables 1, 2). One millili-
ter of peripheral blood was obtained from an arterial line,
placed in EDTA and immediately sent to the laboratory.
Immunocytochemical staining was performed using antibod-
ies from BD Simultest (anti: CD45FITC/CD14PE, IgG1/
/IgG2a, CD3FITC/CD19PE, CD3FITC/CD4PE, CD3FITC/
/CD8PE, CD16FITC/CD16+CD56PE), as described previ-
ously [10]. This panel of antibodies has been international-
ly accepted for studies of leukocyte subpopulations. Brief-
ly, 50 μl of the blood was incubated with 10 μl of labeled
antibody for 30 min at room temperature. Subsequently,
erythrocytes were lysed by the addition of lysing buffer
(Beckton Dickinson). Afterwards, cells were washed twice
with 2% calf serum in phosphate buffer saline, centrifuged
and resuspended in PBS-0.5% formaldehyde. Labeled cells
were analyzed by flow cytometry using the FACS Calibur
cytometer (Beckton Dickinson). 10,000 live leukocytes were
collected from each sample. The obtained data was ana-
lyzed using CellQuest software (BD) and quadrant statis-
tics. WBC was counted in the Burker chamber. Results were
expressed as the total number of a cell type per 1 μl (mm3)
of blood. Normal values for populations and subpopulations
of leukocytes in the peripheral blood of healthy persons were
assayed and were similar to those previously published [11].
Statistical analysis. Results, expressed as median and in-
terquartile ranges (P25–P75 values), were analyzed using
a commercial statistical application StatView 5.12. Most vari-
ables did not fulfill the normality hypothesis, so the Mann–
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–Whitney U-test for non-parametric data was used to ana-
lyze differences between the groups. Correlations between
parameters were assessed using Spearman’s rank correla-
tion. Statistical significance was assumed when p < 0.05.
Results
Patient population
Out of 22 patients with diagnosed sepsis, eight pa-
tients fulfilled the criteria for oneumonia-derived sep-
sis (PDS) including double positive bacteria cultures
from blood and bronchoalveolar lavage fluid (BALf),
and 14 patients had intraabdominal sepsis (IAS) with
double positive cultures from blood and peritoneal
cavity. In the IAS group, five patients had acute ne-
crotizing pancreatitis and the others had complica-
tions after major surgery. Clinical data from these two
groups is summarized in Tables 1 and 2. In the PDS
group, the Gram-positive species were isolated from
six patients (75%), while in the IAS group nine  Gram-
negative species were isolated (71%). The ICU length
of stay and the APACHE II scores and survival (0.38
for PDS and 0.36 for IAS) were comparable in both
groups. Median age of healthy subjects (volunteers)
was 31 (P2526–P7555).
Table 1. Characteristics of patients with pneumonia-derived sepsis
No Sex Age Etiology Shock Apache II Length of ICU Survival White Blood
(Male/Female)  (Yes/No)  stay (days)  (Yes/No)   Cell Count [μl]
1 F 50 G– Y 9 16 Y 11,950
2 M 64 G+ N 9 12 Y 13,325
3 M 40 G– N 6 9 Y 10,450
4 F 53 G+ Y 15 30 N 33,200
5 F 42 G+ N 9 49 N 15,300
6 M 60 G+ N 6 17 N 6,450
7 M 30 G+ N 10 6 N 18,000
8 F 40 G+ Y 9 5 N 1,950
Median or ratio 46 0.75 G+ 0.38 Y 9 14 0.37 Y 12,638
ICU — Intensive Care Unit; APACHE II — Acute Physiology and Chronic Health Evaluation II — scores for the day of sample collection
Table 2. Characteristics of patients with intraabdominal sepsis
No Sex Age Etiology Shock Apache II Length of ICU Survival White Blood
(Male/Female)  (Yes/No)  stay (days)  (Yes/No)   Cell Count [μl]
1 M 27 G– Y 11 85 N 28,750
2 M 50 G– N 9 8 N 13,300
3 F 63 G– Y 12 22 N 25,020
4 M 51 G– N 11 13 N 37,450
5 M 62 G– Y 15 52 N 20,800
6 F 40 G+ Y 4 7 N 15,100
7 F 74 G+ Y 20 43 N 10,640
8 M 48 G– N 9 5 N 29,050
9 M 56 G– N 9 21 N 12,100
10 M 40 G– Y 11 12 Y 14,200
11 F 51 G– Y 13 5 Y 26,150
12 M 83 G– Y 12 13 Y 25,000
13 M 52 G+ N 19 31 Y 14,600
14 M 72 G+ Y 13 13 Y 30,800
Median or ratio 52 0.71 G– 0.64 Y 11.5 13 0.36 Y 25,010
ICU — Intensive Care Unit; APACHE II — Acute Physiology and Chronic Health Evaluation II — scores for the day of sample collection
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Leukocyte subpopulation counts in intraabdominal
sepsis and pneumonia-derived sepsis
The septic patients enrolled in our study had a sig-
nificantly higher value of absolute number of leuko-
cytes compared to the healthy controls (4.10 ratio in
IAS and 2.07 ratio in PDS). This was mainly due to
the increased number of granulocytes (6.76 ratio in
IAS and 3.42 in PDS). Intraabdominal sepsis was char-
acterized by an increase in the absolute monocyte
number (2.03 ratio), while in pneumonia-derived
sepsis a slight decrease was observed (0.76 ratio), as
presented in Figure 1. Lymphocyte subpopulations
including CD3+, CD3+/CD8+, CD3+/CD4+, CD19+
and NK cells were diminished compared to controls
in both types of sepsis. A marked drop of CD3+/
/CD8+, NK and NKT cells was observed, with a ten-
dency to a greater loss in pulmonary infections (Ta-
ble 3, Figure 2).
NK cells and CD8 T lymphocyte counts correlate
independently of the infection type
In order to analyze changes in the immune response
during sepsis, we calculated correlations between lym-
phocyte subsets. During IAS, as well as PDS, total
lymphocyte count per μl correlated positively with the
CD3+ T lymphocytes number (correlation coefficient
r2 = 0.95 and r2 = 0.99, respectively). Correlations
were also found between CD19+ B lymphocyte count
and the total lymphocyte count (correlation coeffi-
cient r2 = 0.85 in IAS and r2 = 0.97 in PDS) and CD4+
T lymphocyte count and T lymphocyte count
(r2 = 0.90 in IAS and in PDS). Interestingly, the CD8+
cytotoxic lymphocyte (CTL) population count better
Figure 1. Absolute number of monocytes per μl of periphe-
ral blood in controls and septic patients
IAS — intraabdominal sepsis; PDS — pneumonia-derived
sepsis. Results expressed as median and P25–P75 values
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correlated with the total lymphocyte count in the PDS
group (r2 = 0.90) than in IAS (r2 = 0.67), as did the
count of NK cell population (r2 = 0.90 in PDS and
r2 = 0.33 in IAS). However, no differences were found
in the count obtained for NK cells and CTL CD3+/
/CD8+ lymphocyte population, independently in both
studied groups of patients. Significant correlations
between lymphocyte subsets and APACHE II were
found in neither IAS nor PDS patients.
Discussion
In this study, we identified differences of the circu-
lating lymphocytes in sepsis derived from different
sites of infection: lungs (PDS) and abdomen (IAS).
The differences were analyzed during the later phase
of sepsis when immune disturbances are well-pro-
nounced. Although sepsis may have heterogeneous
etiology, most studies on human sepsis have not fo-
cused on the site of origin of sepsis. Nevertheless, the
site of origin may be important, as suggested by a few
papers revealing differences in the immune response
during Gram+ and Gram– sepsis. The study by Holub
et al. [4] showed that Gram+ sepsis caused a higher
decrease in CD4+, CD8+, NK cells and total T-lym-
phocytes than Gram– sepsis. The pattern of immune
recovery in Gram+ sepsis was different and slower
than in Gram– infections [4]. Gram positive sepsis is
often related to higher mortality than Gram negative
sepsis [12] and PDS is mostly of G+ etiology, as in
our observations. Another study comparing ventila-
tor associated pneumonia (VAP) with other infections
showed stronger depression of CD4+ lymphocytes and
lower release of TNF by in vitro LPS stimulated mono-
cytes of VAP patients [13].
Our observations revealed differences in the cir-
culating leukocyte populations between sepsis derived
from different sites of infection i.e. the lungs (PDS)
and the abdomen (IAS). Both analyzed types of sep-
sis were characterized by an increase in the granulo-
cyte absolute count, but there was a difference be-
tween them: a higher granulocyte number was present
in IAS. An excess production and release of neutro-
phils to peripheral blood is a known phenomenon in
peritonitis [14, 15], although the migration of poly-
morphonuclear neutrophils to lungs during peritoni-
tis in nonsurviving patients has also been reported
[16]. One of the main functions of this population of
cells is to trap the circulating bacteria within the neu-
trophil DNA-protein net (NET, neutrophil extracel-
lular trap) released from the dying cells [17]. Inter-
estingly, we observed a marked difference in mono-
cyte population counts. While in PDS the monocyte
count decreased, in IAS an increase was observed.
The analysis of peripheral blood leukocytes reflects
either their turn-over or their translocation from cir-
culation to the tissues and reverse. In a recent paper,
Gogos et al. [8] showed similar rates of monocyte
apoptosis in sepsis derived from peritonitis, CAP and
VAP. Given this, our results suggest a translocation
of monocyte population to the inflamed lungs in PDS
which is consistent with the experimental data. Mu-
rine models of local lung inflammation have revealed
a sequestration of bone marrow released monocytes,
but also an observation that transfer of monocytes
from pneumonic animals to healthy animals led to
the accumulation of the activated monocytes in the
healthy lungs [18, 19]. As mentioned above, IAS was
characterized by an increase in the total number of
circulating monocytes which is typical in sepsis de-
rived from peritonitis [20]. This rise in the circulating
monocyte number can be explained by their release
from bone marrow as well as the clearance from peri-
toneal cavity [21].
Our study did not reveal significant differences in
the total count of lymphocytes subpopulations in IAS
and PDS. However, this may be a result of the small
sample size, partially mitigated by the strong differ-
entiation of the two compared groups. The analyzed
lymphocyte counts were lower compared to healthy con-
trols. A tendency to a more pronounced loss of circulat-
ing CD8+ cytotoxic T cells (CTL) and NK cells could be
seen in the pulmonary sepsis. While the decrease of
CD8+ CTL is consistent with previous reports [8, 22],
our observations regarding the population of NK cells
are surprisingly not. Several papers have reported an
increased number of NK cells in sepsis [23, 24].
In order to further investigate elements of cellular
immune response in sepsis, we calculated correlations
between lymphocyte subsets. NK cells and CD8+ cyto-
Figure 2. Absolute number of CD3+CD8+ lymphocytes per
μl of peripheral blood in controls and septic patients
IAS — intraabdominal sepsis; PDS — pneumonia-derived
sepsis. Results expressed as median and P25–P75 values
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toxic lymphocytes counts were correlated with the total
lymphocyte count only in the PDS patients. This might
suggest a different role of these cells during abdominal
and lung infections. CD8+ lymphocytes are known to
play a key role in peritoneal immune mechanisms and
the CD4:CD8 ratio is inverted in the peritoneal fluid
compared to the peripheral blood [5]. During abdomi-
nal infections, these cells may be recruited from the pe-
ripheral blood into the local compartment. The same
might occur with NK cells which are known to be at-
tracted by factors produced by mesothelial cells of the
peritoneal cavity, such as IL-15 which is an important
ligand for both NK cells and CD8+ lymphocytes [25].
Additionally, we found a similar relationship be-
tween NK cells and CD8+ lymphocytes in both types
of sepsis. This finding supports a hypothesis based on
a murine sepsis model that NK and CD8+ lympho-
cytes play an important role in extracellular bacterial
infections [26]. NK cells are known to be major INFg
producers during bacterial sepsis. The INFg cytokine
is produced by NK cells in response to IL-12 and ac-
tivates macrophages (potentiate phagocytosis, oxida-
tive burst, production of TNFa and IL-12) and Th
cells [27]. In the animal CLP-model, it has been shown
that NK cells migrate into the peritoneal cavity where
they appear to facilitate the activation of peritoneal
macrophages [28]. Despite such effects in an infec-
tion, the peripheral blood depletion of NK cells im-
proved the outcome of the septic animals. This effect
was even stronger when the mice were devoid of NK
cells and CD8+ lymphocytes at the same time [26].
Although these cells were not considered as impor-
tant players in extracellular bacterial infections, they
have additive and synergistic effects on each other in
sepsis. Our results suggest the existence of this phe-
nomenon in human sepsis. Gimarellos-Bourboulis et
al. [23] suggested that a high NK cell count was a pos-
itive prognostic factor in G-sepsis, and Monserrat et
al. [22], observed significantly lower CD3+CD8+ T cell
counts in survivors compared to nonsurvivors, but we
did not find any correlation between the clinical state
of patients as evaluated by the APACHE II scale, NK
cells or CD8+ lymphocytes. A correlation between NK
cells and CD3/CD8+ absolute counts may suggest
a common regulatory mechanism for these cell types.
As stated before, INFg produced by NK cells may
favor CD3/CD8+ lymphocytes as IL-12 does. Anoth-
er independent mechanism responsible for this cor-
relation may involve receptors CD94/NKG2 ex-
pressed both by NK cells as well as a subset of CD3/
/CD8+ T-cells active in infections. NKG2A functions
as an inhibitory receptor when forming heterodimers
with an invariant chain, CD94 [29, 31]. Several in vivo
models have shown that the acquisition of CD94/
/NKG2A expression by CD8+ T cells could play a role
during infection by pathogens. As a consequence of
CD8+ T cell activation by an antigen, these cells start
expressing CD94/NKG2A. This has been observed in
mice infected with a variety of pathogens, including List-
eria monocytogenes [31–33]. The expression of CD94/
/NKG2A is acquired early during the infection and per-
sists after the clearance of the pathogen. In some of these
studies, it was shown that the expression of CD94/
/NKG2A by the CD8+ T cells did not inhibit cytotoxic
function of these cells [31, 33]. These receptors are spe-
cific for the nonclassical class I molecule HLA-E in hu-
mans [33–35] and Qa-1b in mice [37]. The other ob-
served function of the CD94/NGK2 receptor is to pro-
tect the NK and CD8 T cells from apoptosis, thereby
perhaps aiding in the generation of memory cells [38].
In conclusion, we have observed that some com-
ponents of the immune response during sepsis may
depend on the site of infection. Intra-abdominal sep-
sis was characterized by a high monocyte count, while
pneumonia-derived sepsis led to a decrease in the
number of circulating monocytes. Both sepsis types
led to the loss of peripheral blood lymphocytes, in-
cluding CD3/CD8+ CTL and NK cells. We also found
similar behavior by the NK cells and CD3/CD8+ CTL
in the course of bacterial sepsis. However, additional
studies on both the NK cells and the CD3/CD8+ cells
in the pathogenesis of human sepsis are needed.
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